Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma.

Liu X, Ogasawara S, Kaneko MK, Oki H, Hozumi Y, Goto K, Takagi M, Kato Y.

Biochem Biophys Res Commun. 2015 Apr 17;459(4):636-42. doi: 10.1016/j.bbrc.2015.02.162. Epub 2015 Mar 6.

PMID:
25753205
2.

Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.

Kato Kaneko M, Ogasawara S, Kato Y.

Tohoku J Exp Med. 2013 Jun;230(2):103-9.

3.

Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations.

Kaneko MK, Tsujimoto Y, Hozumi Y, Goto K, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2013 Jun;32(3):224-8. doi: 10.1089/mab.2013.0006.

PMID:
23750482
4.

Generation of a novel monoclonal antibody WMab-1 specific for IDH2-R172W mutation.

Kato Y, Kaneko MK.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):374-8. doi: 10.1016/j.bbrc.2013.02.106. Epub 2013 Mar 20.

PMID:
23524262
5.

A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation.

Kato Y, Natsume A, Kaneko MK.

Biochem Biophys Res Commun. 2013 Mar 22;432(4):564-7. doi: 10.1016/j.bbrc.2013.02.049. Epub 2013 Feb 26.

PMID:
23485467
6.

Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations.

Kaneko MK, Morita S, Tsujimoto Y, Yanagiya R, Nasu K, Sasaki H, Hozumi Y, Goto K, Natsume A, Watanabe M, Kumabe T, Takano S, Kato Y.

Biochem Biophys Res Commun. 2013 Mar 1;432(1):40-5. doi: 10.1016/j.bbrc.2013.01.088. Epub 2013 Jan 31.

PMID:
23376717

Supplemental Content

Loading ...
Support Center